+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Quest Diagnostics Inc (DGX) - Financial and Strategic SWOT Analysis Review

Quest Diagnostics Inc (DGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a network of laboratories and company-owned patient service centers. It offers a range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, clinical trial testing, life insurer services and various healthcare information technology and diagnostic products. Quest Diagnostics provides its services to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories, and governmental agencies, among others. The company, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. Quest Diagnostics is headquartered in Secaucus, New Jersey, the US.

Quest Diagnostics Inc Key Recent Developments

  • May 06, 2024: Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer
  • Apr 25, 2024: Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity
  • Apr 02, 2024: Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
  • Feb 23, 2024: Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Quest Diagnostics Inc - Key Facts
  • Quest Diagnostics Inc - Key Employees
  • Quest Diagnostics Inc - Key Employee Biographies
  • Quest Diagnostics Inc - Major Products and Services
  • Quest Diagnostics Inc - History
  • Quest Diagnostics Inc - Company Statement
  • Quest Diagnostics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Quest Diagnostics Inc - Business Description
  • Business Segment: Diagnostic Information Services (DIS) Business
  • Overview
  • Performance
  • Business Segment: DS businesses
  • Overview
  • Performance
  • R&D Overview
  • Quest Diagnostics Inc - Corporate Strategy
  • Quest Diagnostics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Quest Diagnostics Inc - Strengths
  • Quest Diagnostics Inc - Weaknesses
  • Quest Diagnostics Inc - Opportunities
  • Quest Diagnostics Inc - Threats
  • Quest Diagnostics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Quest Diagnostics Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Quest Diagnostics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 06, 2024: Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer
  • Apr 25, 2024: Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity
  • Apr 02, 2024: Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
  • Feb 23, 2024: Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference
  • Feb 12, 2024: First PFAS “Forever Chemicals” Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com
  • Feb 01, 2024: Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share
  • Jan 17, 2024: Fitbit and Quest Diagnostics Collaborate to Advance Research on the Use of Wearable Devices to Improve Metabolic Health
  • Jan 09, 2024: Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing
  • Dec 21, 2023: Quest Diagnostics to Speak at the 42nd Annual J.P. Morgan Healthcare Conference
  • Dec 20, 2023: Quest Diagnostics Names Yuri A. Fesko, M.D., Senior Vice President and Chief Medical Officer
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Quest Diagnostics Inc, Key Facts
  • Quest Diagnostics Inc, Key Employees
  • Quest Diagnostics Inc, Key Employee Biographies
  • Quest Diagnostics Inc, Major Products and Services
  • Quest Diagnostics Inc, History
  • Quest Diagnostics Inc, Subsidiaries
  • Quest Diagnostics Inc, Joint Venture
  • Quest Diagnostics Inc, Key Competitors
  • Quest Diagnostics Inc, Ratios based on current share price
  • Quest Diagnostics Inc, Annual Ratios
  • Quest Diagnostics Inc, Annual Ratios (Cont...1)
  • Quest Diagnostics Inc, Annual Ratios (Cont...2)
  • Quest Diagnostics Inc, Interim Ratios
  • Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Quest Diagnostics Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Quest Diagnostics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Quest Diagnostics Inc, Performance Chart (2019 - 2023)
  • Quest Diagnostics Inc, Ratio Charts
  • Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Quest Diagnostics Inc, Medical Equipment, Deals by Type, 2018 to YTD 2024

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Thermo Fisher Scientific Inc
  • Celcuity Inc
  • Alere Inc
  • Psychemedics Corp
  • Nymox Pharmaceutical Corp
  • Novant Health Inc
  • RadNet Inc
  • Net Medical Xpress Solutions Inc
  • Laboratory Corp of America Holdings
  • Bio-Rad Laboratories Inc
  • Life Technologies Corp
  • Personalis Inc
  • OpGen Inc